I2I Apr. 25, 2016 – FDA 101


The Office of Technology Commercialization
Invention 2 Innovation (I2I)

“FDA 101: ‘Why, What, and How To’ of Drug Devleopment”

Monday, April 25, 2016
12:00 pm – 1:30 pm
Leavey Program Room at the Leavey Center (Across from the bookstore.)

Presented by: 

Dr. Jesse L. Goodman, M.D., M.P.H.
Georgetown University School of Medicine

 Dr. Goodman, a renowned expert in infectious diseases, is the founding  director of the Center on Medical Product Access, Safety and Stewardship  (COMPASS) at Georgetown.  He is a member of the Institute of Medicine and  was most recently Chief Scientist of the Food and Drug Administration  (FDA) (from 2009 until February 2014) where he also founded and co-  chaired the first U.S. Task Force to Combat Antimicrobial Resistance and  directed the Center for Biologics Evaluation and Research.  He worked  extensively with industry, academia, government and global public health  partners to prepare for and respond to major public health threats  including bioterrorism and West Nile Virus, and led the FDA’s response to  the 2009 H1N1 pandemic.

Lunch will be provided, space is limited.
Please RSVP by Friday, April 22, 2016
to Jeremy S. Alexander at jsa28 at georgetown dot edu or 202.687.7424.

Faculty, entrepreneurs, fellows, business students, medical students, law students and research administrators are encouraged to attend.